LONDON (Alliance News) - Biotechnology company Tiziana Life Sciences PLC on Tuesday said it has raised GBP3.8 million through a convertible loan note issue.
The company said it has issued 2.6 million notes, convertible at 150.00 pence per share. Shares in Tiziana were down 1.7% to 199.00p.
The funds will be used to fund the development of the company's clinical stage assets, including thymic carcinoma treatment candidate milciclib and autoimmune and inflammatory diseases treatment foralumab.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
